molab.ai GmbH

Startup

molab.ai provides drug discovery teams with an AI backbone to accelerate and streamline hit identification, hit-to-lead processes, and lead optimization. The molab.ai platform delivers highly accurate ADMET property predictions as well as suggestions for novel, alternative molecular structures optimized for improved binding affinity, desirable ADMET properties and synthetic accessibility. molab.ai predictions robustly outperform alternative AI/ML solutions as well as physics-based models, provide extremely accurate confidence indicators and, importantly, have been shown to generalize well to novel chemical space. Moreover, molab.aialgorithms are readily usable for the most important ADMET properties as well as common targets and can be adapted with client data, when desired.